Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia
奥妥珠单抗、伊布替尼和维奈托克联合治疗初治及复发或难治性慢性淋巴细胞白血病的II期研究
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.20.00491
Rogers, Kerry A; Huang, Ying; Ruppert, Amy S; Abruzzo, Lynne V; Andersen, Barbara L; Awan, Farrukh T; Bhat, Seema A; Dean, Allison; Lucas, Margaret; Banks, Christin; Grantier, Cara; Heerema, Nyla A; Lozanski, Gerard; Maddocks, Kami J; Valentine, Thomas R; Weiss, David M; Jones, Jeffrey A; Woyach, Jennifer A; Byrd, John C